Ads
related to: life expectancy with liver metastases prognosis chart- uHCC Treatment Option
Patients: Learn More About A
Hepatocellular Carcinoma Treatment.
- Dosing Info For Patients
See Dosing & Treatment Info
For A uHCC Treatment Option.
- Patient & Caregiver Info
Learn More About uHCC & A
Treatment Option That Could Help.
- Plan for uHCC Treatment
Diagnosis Can Be A Shock. Learn
How To Prepare For uHCC Treatment.
- Patient & Caregiver Site
See Resources & Financial Support
For uHCC Patients & Caregivers.
- uHCC Patient Information
Recently Diagnosed With uHCC?
Learn More About A Treatment Option
- uHCC Treatment Option
Search results
Results From The WOW.Com Content Network
A liver metastasis is a malignant tumor in the liver that has spread from another organ that is affected by cancer. The liver is a common site for metastatic disease because of its rich, dual blood supply (the liver receives blood via the hepatic artery and portal vein). Metastatic tumors in the liver are 20 times more common than primary liver ...
The National Institute of Health (NIH) attributes the increase in the 5-year relative survival of prostate cancer (from 69% in the 1970s to 100% in 2006) to screening and diagnosis and due to the fact that men that participate in screening tend to be healthier and live longer than the average man and testing techniques that are able to detect ...
Liver cancer can be primary in which the cancer starts in the liver, or it can be liver metastasis, or secondary, in which the cancer spreads from elsewhere in the body to the liver. Liver metastasis is the more common of the two liver cancers. [3] Instances of liver cancer are increasing globally. [8] [9]
Barcelona Clinic Liver Cancer (BCLC) Staging System. The prognosis of HCC is affected by the staging of the tumor, the liver's function due to the effects of chronic liver disease and cirrhosis as well as the person's physical performance status. [48] A number of staging classifications for HCC are available.
The Model for End-Stage Liver Disease, or MELD, is a scoring system for assessing the severity of chronic liver disease.It was initially developed to predict mortality within three months of surgery in patients who had undergone a transjugular intrahepatic portosystemic shunt (TIPS) procedure, [1] and was subsequently found to be useful in determining prognosis and prioritizing for receipt of ...
Survival rate is a part of survival analysis.It is the proportion of people in a study or treatment group still alive at a given period of time after diagnosis. It is a method of describing prognosis in certain disease conditions, and can be used for the assessment of standards of therapy.
Ads
related to: life expectancy with liver metastases prognosis chart